# Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site

> **NCT07325864** · — · RECRUITING · sponsor: **European Institute of Oncology** · enrollment: 25 (estimated)

## Conditions studied

- NSCLC
- Lung Cancer (Diagnosis)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07325864
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-18
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07325864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07325864, "Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07325864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*